Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Alpha-1-antitrypsin deficiency - an update].

Deutsche medizinische Wochenschrift (1946) - 1 Sept 2016

Bernhard Nikolas, Bals Robert, Fähndrich Sebastian

Abstract excerpt

Alpha-1-antitrypsin deficiency is a genetic risk factor for the development of chronic obstructive airway disease (COPD) and liver cirrhosis. The disease is widely underdiagnosed. The hallmarks of therapy are smoking cessation, prevention from environmental dust exposure and augmentation therapy. Findings from the recently published prospective, placebo-controlled and randomized RAPID trial proved effectiveness...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Evidence-Based Medicine
Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Emphysema

Share to Genetic Predisposition to Disease

Share to Respiratory Function Tests

Share to Tomography, X-Ray Computed

Share to Treatment Outcome

Source

Identifiers

PMID: 27701692
DOI: 10.1055/s-0042-112096

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Alpha-1-antitrypsin deficiency - an update].PMID 27701692Read ↗

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency: outstanding questions and future directionsSemantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

A Review of α1-Antitrypsin DeficiencySemantic proximity Read ↗

Alpha-1 Antitrypsin Augmentation TherapySemantic proximity Read ↗

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.Semantic proximity Read ↗

Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.Semantic proximity Read ↗

Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.Semantic proximity Read ↗

Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.Semantic proximity Read ↗

Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicineSemantic proximity Read ↗

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

A review of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.